hrp0098p2-93 | Fat, Metabolism and Obesity | ESPE2024

Prevalence of metabolic syndrome components and atherogenic index in obese nondiabeticchildren: anthropometric comparison with parents

Hamed Noor , Soliman Ashraf , Alyafei Fawzia , Ahmed Shayma , Alaaraj Nada , Shaat Mona , Bedair Abdelrahman

Background: The global prevalence of childhood and adolescent obesity has surged since 1980, reaching 107.7 million cases in 2015. Notably, 23% of children in developed countries are overweight or obese. The Atherogenic Index of Plasma (AIP) emerges as a novel, robust biomarker, closely linked to obesity, and serves as a reliable indicator of dyslipidemia and associated conditions, including cardiovascular diseases.Aim: ...

hrp0098p2-272 | Thyroid | ESPE2024

Thyroid function during GH therapy in children with GHD versus those with ISS

Alaaraj Nada , Soliman Ashraf , Alyafei Fawzia , Hamed Noor , Ahmed Shayma , Elsayed Nagwa , Bedair Abdelrahman

Introduction: Hypothyroidism in children leads to growth retardation. However, there is some evidence that recombinant human growth hormone (rhGH) therapy could suppress thyroid function. The actual incidence is controversial, however, with some studies showing a rare and others a high occurrence.Aim and Methods: This study examines the effects of Growth Hormone (GH) therapy on thyroid function, specifically focusing on ...